Sponsor pipeline

Jean-Pierre Van geertruyden clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

First posted	Trial	Phase	Status
2026-09-25	NCT07842107 Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic…	Phase 2/3	Not Yet Recruiting

Phase 2/3		1
Phase 3		2

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT06844487	Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC	Mpox (Monkeypox)	Active, Not Recruiting	2026-04-29
NCT06844500	Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC	Neonate	Active, Not Recruiting	2026-01-30
Phase 2/3
NCT07842107	Study of Vaccines Against Bundibugyo Virus Disease in Contacts of Cases in the Democratic…	Ebola Hemorrhagic Fever	Not Yet Recruiting	2026-10-05

Get alerts when Jean-Pierre Van geertruyden's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.